JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 30, 2006; DOI: 10.1124/jpet.106.102319


0022-3565/06/3181-238-245$20.00
JPET 318:238-245, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.102319v1
318/1/238    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, Y.-S.
Right arrow Articles by Quirion, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, Y.-S.
Right arrow Articles by Quirion, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

NEUROPHARMACOLOGY

Specific Plasma Membrane Binding Sites for Polyphenols, Including Resveratrol, in the Rat Brain

Ying-Shan Han, Stéphane Bastianetto, Yvan Dumont, and Rémi Quirion

Douglas Hospital Research Centre, Department of Psychiatry, McGill University, Montréal, Québec, Canada

Using [3H]resveratrol (3,5,4'-trihydroxy-trans-stilbene) as radioligand, we investigated the possible existence of specific polyphenol binding sites at the level of the cellular plasma membrane in rat brain. Specific [3H]resveratrol binding sites were found to be enriched in the plasma membrane pellet with lower levels in the nuclear and cell debris fraction. Specific [3H]resveratrol binding to the plasma membrane fraction was sensitive to trypsin digestion and protein denaturation but not to DNase and RNase treatment. Saturation binding experiments revealed that specific [3H]resveratrol recognized a single class of sites with an apparent affinity (KD) of 220 ± 45 nM and a maximal capacity (Bmax) of 1060 ± 120 fmol/mg protein. Various polyphenols and resveratrol derivatives competed against specific [3H]resveratrol binding in rat brain plasma membrane homogenates with the tea catechin gallates (epigallocatechin gallate and epicatechin gallate) displaying the highest affinities (Ki = 25-45 nM) followed by resveratrol (Ki = 102 nM). Quantitative autoradiographic studies revealed that specific [3H]resveratrol binding sites are broadly distributed in the rat brain, with highest levels of labeling seen in the choroid plexus and subfornical organ. Finally, the potency of various polyphenols and resveratrol analogs in protecting hippocampal cells against beta-amyloid-induced toxicity correlated well (r = 0.74) with their apparent affinity in the [3H]resveratrol binding assay. Taken together, these results suggest that the neuroprotective action of various polyphenols and resveratrol analogs could be mediated by the activation of common "receptor" binding sites particularly enriched at the level of the cellular plasma membrane in the rat brain.


Received February 2, 2006; accepted March 28, 2006.

Address correspondence to: Dr. Rémi Quirion, Douglas Hospital Research Center, 6875 Blvd. LaSalle, Montréal (Verdun), QC H4H 1R3, Canada. E-mail: remi.quirion{at}douglas.mcgill.ca




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Seely, M. S. Levi, and P. L. Prather
The Dietary Polyphenols trans-Resveratrol and Curcumin Selectively Bind Human CB1 Cannabinoid Receptors with Nanomolar Affinities and Function as Antagonists/Inverse Agonists
J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 31 - 39.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.